Publication | Open Access
Mitochondrial Ca2+ Overload Underlies Aβ Oligomers Neurotoxicity Providing an Unexpected Mechanism of Neuroprotection by NSAIDs
212
Citations
49
References
2008
Year
Synaptic TransmissionCell DeathAmyloid Beta PeptideSynaptic SignalingSocial SciencesOxidative StressNeuroinflammationAlzheimer's DiseaseDegenerative PathologyProtein MisfoldingNeurologyNeurochemistryMolecular NeuroscienceBiochemistryNeuropharmacologyMitochondrial CaNeuroprotectionPharmacologyAbeta OligomersNeurodegenerative DiseasesUnexpected MechanismDementiaNeuroscienceMolecular NeurobiologyMedicine
Dysregulation of intracellular Ca(2+) homeostasis may underlie amyloid beta peptide (Abeta) toxicity in Alzheimer's Disease (AD) but the mechanism is unknown. In search for this mechanism we found that Abeta(1-42) oligomers, the assembly state correlating best with cognitive decline in AD, but not Abeta fibrils, induce a massive entry of Ca(2+) in neurons and promote mitochondrial Ca(2+) overload as shown by bioluminescence imaging of targeted aequorin in individual neurons. Abeta oligomers induce also mitochondrial permeability transition, cytochrome c release, apoptosis and cell death. Mitochondrial depolarization prevents mitochondrial Ca(2+) overload, cytochrome c release and cell death. In addition, we found that a series of non-steroidal anti-inflammatory drugs (NSAIDs) including salicylate, sulindac sulfide, indomethacin, ibuprofen and R-flurbiprofen depolarize mitochondria and inhibit mitochondrial Ca(2+) overload, cytochrome c release and cell death induced by Abeta oligomers. Our results indicate that i) mitochondrial Ca(2+) overload underlies the neurotoxicity induced by Abeta oligomers and ii) inhibition of mitochondrial Ca(2+) overload provides a novel mechanism of neuroprotection by NSAIDs against Abeta oligomers and AD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1